eFFECTOR Therapeutics, Inc. — key financial figures for fiscal year 2023 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2023)

$0

Net Income/Loss (FY2023)

-$35.8M

Total Assets (FY2023)

$20.5M

Total Equity (FY2023)

-$5.8M

Cash Flows from Operating Activities (FY2023)

-$29.6M

Source: eFFECTOR Therapeutics, Inc. 10-K filing (FY2023). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.